Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
WEHI receives $2.5 million fund to develop personalized cancer treatments

WEHI receives $2.5 million fund to develop personalized cancer treatments

New type of chip could lead to earlier and more targeted treatment for cancer

New type of chip could lead to earlier and more targeted treatment for cancer

ZDHHC18-mediated MDH2 palmitoylation upholds mitochondrial respiration and boosts ovarian cancer malignancy

ZDHHC18-mediated MDH2 palmitoylation upholds mitochondrial respiration and boosts ovarian cancer malignancy

Researchers analyze the involvement of immune cells in lung cancer survival

Researchers analyze the involvement of immune cells in lung cancer survival

Study shows new potential target for CAR T cells to inhibit solid tumors

Study shows new potential target for CAR T cells to inhibit solid tumors

Scientists discover an effective drug development candidate from rare actinomycetes

Scientists discover an effective drug development candidate from rare actinomycetes

A new rule book for the design of therapeutic cells with improved specificity and safety

A new rule book for the design of therapeutic cells with improved specificity and safety

Study reveals key characteristics of immune cells in ovarian cancer

Study reveals key characteristics of immune cells in ovarian cancer

Specialist assay kits and microplates for cancer research

Specialist assay kits and microplates for cancer research

Study identifies a new cancer cell state related to poor treatment response in ovarian cancer patients

Study identifies a new cancer cell state related to poor treatment response in ovarian cancer patients

Study identifies genes that protect ovarian cancer from antitumor immunity

Study identifies genes that protect ovarian cancer from antitumor immunity

Constitutive BAK/MCL1 complexes could predict sensitivity of chemotherapy drugs, research shows

Constitutive BAK/MCL1 complexes could predict sensitivity of chemotherapy drugs, research shows

Researchers reveal how cancerous tissues develop resistance to platinum-based cytotoxic drugs

Researchers reveal how cancerous tissues develop resistance to platinum-based cytotoxic drugs

Study analyzes individuals’ stance on secondary genomic findings

Study analyzes individuals’ stance on secondary genomic findings

Study on protein complex could help support cancer prevention efforts, drug development

Study on protein complex could help support cancer prevention efforts, drug development

Pushing organ-on-a-chip microdevices to new levels to improve ovarian cancer treatment

Pushing organ-on-a-chip microdevices to new levels to improve ovarian cancer treatment

Cell couriers offer clue to how cancers metastasize into secondary tumors

Cell couriers offer clue to how cancers metastasize into secondary tumors

Liver fibrosis might be treatable with selective immunotoxins

Liver fibrosis might be treatable with selective immunotoxins

Scientists unravel the proteins that trigger some cancerous tumors

Scientists unravel the proteins that trigger some cancerous tumors

Odor-based test accurately distinguishes hard-to-detect cancers

Odor-based test accurately distinguishes hard-to-detect cancers